US Patent 9079971 Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Patent 9079971 was granted and assigned to Ambrx on July, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+74 characters)
Article
Patent abstract
Modified FGF-21 polypeptides and uses thereof are provided.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09079971 Modified FGF-21 polypeptides comprising non-naturally occurring amino acids US Patent 9079971 Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Infobox
Patent Number
090799710
Patent Number
90799710
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
090799710
Date of Patent
July 14, 2015
0Patent Application Number
137325220
Date Filed
January 2, 2013
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09079971 Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09079971
Date of patent
July 14, 2015
Patent application number
13732522
Date Filed
January 2, 2013
Patent primary examiner
Find more entities like US Patent 9079971 Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
